Literature DB >> 12925852

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.

Woong-Kyung Suh1, Beata U Gajewska, Hitoshi Okada, Matthew A Gronski, Edward M Bertram, Wojciech Dawicki, Gordon S Duncan, Jacob Bukczynski, Suzanne Plyte, Andrew Elia, Andrew Wakeham, Annick Itie, Stephen Chung, Joan Da Costa, Sudha Arya, Tom Horan, Pauline Campbell, Kevin Gaida, Pamela S Ohashi, Tania H Watts, Steven K Yoshinaga, Mark R Bray, Manel Jordana, Tak W Mak.   

Abstract

We investigated the in vivo function of the B7 family member B7-H3 (also known as B7RP-2) by gene targeting. B7-H3 inhibited T cell proliferation mediated by antibody to T cell receptor or allogeneic antigen-presenting cells. B7-H3-deficient mice developed more severe airway inflammation than did wild-type mice in conditions in which T helper cells differentiated toward type 1 (T(H)1) rather than type 2 (T(H)2). B7-H3 expression was consistently enhanced by interferon-gamma but suppressed by interleukin 4 in dendritic cells. B7-H3-deficient mice developed experimental autoimmune encephalomyelitis several days earlier than their wild-type littermates, and accumulated higher concentrations of autoantibodies to DNA. Thus, B7-H3 is a negative regulator that preferentially affects T(H)1 responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925852     DOI: 10.1038/ni967

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  206 in total

1.  B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.

Authors:  Hao Liu; Christina Tekle; Yih-Wen Chen; Alexandr Kristian; Yuhua Zhao; Ming Zhou; Zixing Liu; Yan Ding; Bin Wang; Gunhild Mari Mælandsmo; Jahn Marthin Nesland; Oystein Fodstad; Ming Tan
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

Review 2.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

3.  Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Authors:  Roberta Castriconi; Alessandra Dondero; Raffaella Augugliaro; Claudia Cantoni; Barbara Carnemolla; Angela Rita Sementa; Francesca Negri; Romana Conte; Maria Valeria Corrias; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

4.  The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization.

Authors:  W-K Suh; S X Wang; A H Jheon; L Moreno; S K Yoshinaga; B Ganss; J Sodek; M D Grynpas; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-18       Impact factor: 11.205

5.  Inhibitors of B7-CD28 costimulation in urologic malignancies.

Authors:  R Houston Thompson; Eugene D Kwon; James P Allison
Journal:  Immunotherapy       Date:  2009-01       Impact factor: 4.196

6.  The expression and distribution of immunomodulatory proteins B7-H1, B7-DC, B7-H3, and B7-H4 in rheumatoid synovium.

Authors:  Guoning Guo; Yongjun Shang; Guoyan Zhu; Xiaoren Bao; Shiwei Xu; Yongwen Chen
Journal:  Clin Rheumatol       Date:  2011-07-22       Impact factor: 2.980

7.  BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.

Authors:  Thang Nguyen; Xikui K Liu; Yongliang Zhang; Chen Dong
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

8.  Murine b7-h3 is a co-stimulatory molecule for T cell activation.

Authors:  Ruhong Yan; Shun Yang; Aiping Gu; Fuqin Zhan; Chunyan He; Chenhao Qin; Xueguang Zhang; Ping Feng
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-12

Review 9.  The role of B7 family molecules in hematologic malignancy.

Authors:  Paul Greaves; John G Gribben
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  Structure and T cell inhibition properties of B7 family member, B7-H3.

Authors:  Vladimir Vigdorovich; Udupi A Ramagopal; Eszter Lázár-Molnár; Eliezer Sylvestre; Jun Sik Lee; Kimberly A Hofmeyer; Xingxing Zang; Stanley G Nathenson; Steven C Almo
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.